title: Is there clear and convincing evidence of cardiovascular risk with rosiglitazone?
authors: Division of Cardiology, Cedars-Sinai Medical Center, and David Geffen School of Medicine, University of California, Los Angeles, California, USA. kaul@cshs.org
authors: S
authors: S
authors: Kaul
authors: G A
authors: GA
authors: Diamond